- Home
- TFIN vs ORIC Comparison
TFIN vs ORIC Comparison
Compare TFIN & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFIN
- ORIC
- Stock Information
- Founded
- TFIN 1981
- ORIC 2014
- Country
- TFIN United States
- ORIC United States
- Employees
- TFIN N/A
- ORIC N/A
- Industry
- TFIN Major Banks
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- TFIN Finance
- ORIC Health Care
- Exchange
- TFIN Nasdaq
- ORIC Nasdaq
- Market Cap
- TFIN 1.2B
- ORIC 1.1B
- IPO Year
- TFIN N/A
- ORIC 2020
- Fundamental
- Price
- TFIN $54.43
- ORIC $12.52
- Analyst Decision
- TFIN Buy
- ORIC Strong Buy
- Analyst Count
- TFIN 4
- ORIC 8
- Target Price
- TFIN $62.00
- ORIC $16.57
- AVG Volume (30 Days)
- TFIN 280.2K
- ORIC 1.4M
- Earning Date
- TFIN 10-15-2025
- ORIC 11-06-2025
- Dividend Yield
- TFIN N/A
- ORIC N/A
- EPS Growth
- TFIN N/A
- ORIC N/A
- EPS
- TFIN 0.28
- ORIC N/A
- Revenue
- TFIN $412,291,000.00
- ORIC N/A
- Revenue This Year
- TFIN $10.80
- ORIC N/A
- Revenue Next Year
- TFIN $11.33
- ORIC N/A
- P/E Ratio
- TFIN $194.74
- ORIC N/A
- Revenue Growth
- TFIN 3.78
- ORIC N/A
- 52 Week Low
- TFIN $42.90
- ORIC $3.90
- 52 Week High
- TFIN $110.58
- ORIC $14.93
- Technical
- Relative Strength Index (RSI)
- TFIN 49.57
- ORIC 50.19
- Support Level
- TFIN $53.03
- ORIC $12.75
- Resistance Level
- TFIN $61.26
- ORIC $13.57
- Average True Range (ATR)
- TFIN 2.91
- ORIC 0.76
- MACD
- TFIN 0.07
- ORIC -0.11
- Stochastic Oscillator
- TFIN 54.67
- ORIC 38.63
About TFIN Triumph Financial Inc.
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.